Trichorabdal A exhibits significant anti-inflammatory and neuroprotective properties, making it a compound of interest in the development of treatments for neurodegenerative diseases such as Alzheimer's and Parkinson's. It has been shown to inhibit key inflammatory pathways in the central nervous system, particularly by suppressing the activation of microglial cells and reducing the production of pro-inflammatory cytokines like TNF-α and IL-6. This activity helps mitigate neuronal damage caused by chronic inflammation.

In addition, Trichorabdal A demonstrates potent antioxidant effects, protecting neuronal cells from oxidative stress, a major contributor to aging and neurodegeneration. Its ability to cross the blood-brain barrier enhances its potential as a therapeutic agent for brain-related disorders.

Recent studies also suggest antiviral activity, particularly against certain RNA viruses, indicating possible application in antiviral drug research. Due to its natural origin and multi-target biological effects, Trichorabdal A is being explored as a lead compound for designing novel neuroprotective and anti-inflammatory agents.